Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, ...
Weight-loss jabs are the latest craze for shedding a few pounds. Their effect has been dramatic with drugs such as Ozempic ...
If you’re intrigued by weight-loss jabs but not in a place to commit, try honing your diet instead. Our experts share tips ...
Menopausal hormone therapy is linked to increased risks for diagnosis of and surgery for strabismus, and researchers detect ...
Nestle's chefs are working with people taking GLP-1 drugs to develop new flavour combinations, including potentially using ...
For years, women have endured hot flashes, mood swings and fatigue in the transition leading up to menopause. Previous ...
G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, regulating diverse ...
Vertex Pharma has made the largest acquisition in its history, agreeing to buy Crinetics Pharma for around $10 billion in a ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...
Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...
New York, USA - Educational release summarizes research-use-only compounds receiving attention in laboratory and preclinical study environments PureRawz today announced the publication of a 2026 ...
Medicines first developed to treat type 2 diabetes are proving to have benefits far beyond controlling blood sugar. A major new study has found that a group of drugs called GLP-1 receptor agonists can ...